Fisher Funds Management LTD

Position in EW — Edwards Lifesciences Corp

CIK 1435028 AUCKLAND, Q2

Position in EW

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$35,971,057

-$5,638,030 QoQ

Shares Held

397,646

-23.5% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

#127

of 1,315 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fisher Funds Management LTD holds $144,868,330 across 5 Medical Devices names. EW ranks #3 (24.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc	840,950	$56,637,982
2	BSX	Boston Scientific Corp	1,007,864	$43,015,635
3	EW	Edwards Lifesciences Corp This page	397,646	$35,971,057
4	ABT	Abbott Laboratories	59,326	$5,383,241
5	MDT	Medtronic plc	49,347	$3,860,415

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,971,057	397,646	-23.5%	Shares	Sole	2026-07-14
2026-03-31	$41,609,087	519,594	-31.8%	Shares	Sole	2026-04-16
2025-12-31	$64,951,889	761,899	-14.2%	Shares	Sole	2026-01-26
2025-09-30	$69,028,340	887,596	-6.4%	Shares	Sole	2025-10-29
2025-06-30	$74,155,671	948,161	+13.9%	Shares	Sole	2025-08-04
2025-03-31	$60,337,788	832,475	-12.8%	Shares	Sole	2025-04-29
2024-12-31	$70,706,053	955,100	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.